2017 annual financial data
Ovid Therapeutics 2017 Operating margin
Ovid Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -65,007,563 USD and net income was -64,806,054 USD.
Operating cash flow was -31,469,909 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -65,007,563 USD
- Net income
- -64,806,054 USD
- Operating cash flow
- -31,469,909 USD